These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3842129)

  • 1. Diagnostic role of urine cytology and fibrinogen degradation products in carcinoma of bladder.
    Misra K; Chowhan JS; Gupta RL; Sagreiya K
    Indian J Cancer; 1985 Jun; 22(2):145-51. PubMed ID: 3842129
    [No Abstract]   [Full Text] [Related]  

  • 2. [The investigation on early diagnosis of the bladder tumor. II: A study on urinary cytology, urinary fibrin/fibrinogen degradation products, tissue fibrin deposition and tissue plasminogen activator activity in patients with bladder tumors (author's transl)].
    Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1980 Sep; 71(9):1047-54. PubMed ID: 7193258
    [No Abstract]   [Full Text] [Related]  

  • 3. [The investigation on early diagnosis of the bladder tumor. I: A study on urinary cytology and urinary fibrin/fibrinogen degradation products (FDP) assay in patient with bladder tumor (author's transl)].
    Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1979 May; 70(5):553-62. PubMed ID: 470263
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
    J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of urine cytology in the diagnosis of recurrent bladder tumors. A preliminary report.
    reichborn-Kjennerud S; Hoeg K
    Acta Cytol; 1972; 16(3):269-72. PubMed ID: 4503072
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative analysis of rapid urine tests for the diagnosis of upper urinary tract malignancy.
    Siemens DR; Morales A; Johnston B; Emerson L
    Can J Urol; 2003 Feb; 10(1):1754-8. PubMed ID: 12625854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of urinary cytology in vesical carcinoma].
    Netto Júnior NR; Hernandez AJ; Lemos GC; França LC
    AMB Rev Assoc Med Bras; 1981 Jul; 27(7):200-2. PubMed ID: 6977152
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the impact of urine cytology screening using a computer-based model of bladder cancer.
    Ellwein LB; Farrow GM; Friedell GH; Greenfield RE
    Urol Clin North Am; 1984 Nov; 11(4):585-98. PubMed ID: 6506371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine cytology: early diagnosis of induced carcinoma of the rat urinary bladder.
    Reznik G; Brennan LM; Creasia DA
    Anticancer Res; 1981; 1(6):389-92. PubMed ID: 7344612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytodiagnosis of urine in bladder neoplasms].
    Suzuki S; Shimaya M; Terao E
    Nihon Rinsho; 1976 Nov; 34(11):3340-3. PubMed ID: 1034777
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
    Moonen PM; Kiemeney LA; Witjes JA
    Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of urine cytology].
    Böck D; Dobrovits G
    Helv Chir Acta; 1973 Sep; 40(4):545-7. PubMed ID: 4753399
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytohistological examination of the urine in diagnosis of neoplasms of the bladder. Considerations on 5 years of experience].
    Zolfanelli R; Conti P; Acanfora F; Barasolo E; Cagna G; Bollero E; Biroli E
    Minerva Urol; 1976; 28(4):161-6. PubMed ID: 798121
    [No Abstract]   [Full Text] [Related]  

  • 15. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
    Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
    Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of biological markers in bladder cancer.
    Wajsman Z; Merrin CE; Chu TM; Moore RH; Murphy GP
    J Urol; 1975 Dec; 114(6):879-93. PubMed ID: 1195467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder.
    Leyh H; Hall R; Mazeman E; Blumenstein BA
    Urology; 1997 Jul; 50(1):49-53. PubMed ID: 9218018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytologic diagnosis of occult and "in-situ" carcinoma of the urinary system.
    Allegra SR; Fanning JP; Streker JF; Corvese NM
    Acta Cytol; 1966; 10(5):340-9. PubMed ID: 5230228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.